Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy

Autor: Rocio, Jiménez-Galán, Maria-Rosa, Cantudo Cuenca, María Aguas, Robustillo-Cortés, Y, Borrego Izquierdo, Carmen Victoria, Almeida-Gonzalez, Ramón, Morillo-Verdugo

Publikováno v: Farmacia Hospitalaria, Vol 40, Iss 4, Pp 272-278 (2016)
Farmacia Hospitalaria v.40 n.4 2016
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

Decreased antiretroviral therapy persistence is associated with increased rates of virologic failure, development of antiretroviral resistance, and increased morbidity and mortality. Different therapeutic strategies, such as single-tablet regimens (S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3d090bb38a7eb0f553295c57d28729b4
http://www.aulamedica.es/fh/pdf/10453.pdf

[New drugs in the treatment of chronic hepatitis C]

Autor: R, Jimenez Galan, A, Albacete Ramirez, P, Monje Agudo, Y, Borrego Izquierdo, R, Morillo Verdugo

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 38(3)

To analyze the efficacy and safety of the new direct antiviral agents (DAA) that will become the new therapeutic arsenal for the treatment of hepatitis C.We carried out a research in the electronic database with the following criteria: phase II and I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a5af49e288481d15b35d318bf2f2f5f3
https://pubmed.ncbi.nlm.nih.gov/24951909

DI-093 Predictors of non-adherence to highly active antiretroviral therapy in HIV-infected patients

Autor: C Haro Márquez, M Manzano Garcia, R Jimenez Galan, R Morillo Verdugo, E Calvo Cidoncha, E Gómez Fernández, Cantudo Cuenca, Y Borrego Izquierdo, F Orantes Casado de Amezua, M Robustillo Cortes

Publikováno v: European Journal of Hospital Pharmacy. 22:A111.1-A111

Background Highly active antiretroviral therapy (HAART) has significantly reduced morbidity and mortality, transforming HIV into a chronic disease. The increase in life expectancy in these patients has led to a higher prevalence of comorbidities and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e53ff49f170b31ef9ca37e14b9cd986
https://doi.org/10.1136/ejhpharm-2015-000639.267

OHP-053 Effect of consulting a pharmacist specialising in viral diseases on the change of antiretroviral treatment

Autor: Cantudo-Cuenca, R Jiménez-Galán, E Gómez-Fernández, Ramón Morillo-Verdugo, AM Tristancho-Pérez, A Albacete-Ramirez, J González-Bueno, E Calvo-Cidoncha, Y Borrego-Izquierdo, MA Robustillo-Cortés

Publikováno v: European Journal of Hospital Pharmacy. 21:A206.2-A207

Background Pharmaceutical care consultations specialising in viral diseases seem to benefit the therapeutic objective. Purpose To analyse the frequency of changes in antiretroviral treatment regimens (ART) when the patient is able to consult a pharma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::03c279cb3977d3bf514bc50297d39d8e
https://doi.org/10.1136/ejhpharm-2013-000436.505

CP-030 Analysis of antiretroviral treatment changes in HIV-infected patients

Autor: E Calvo Cidoncha, Cantudo Cuenca, RM Damas Fuentes, P Monje Agudo, M. R. Cantudo Cuenca, M Robustillo Cortes, C Gómez Peña, Y Borrego Izquierdo, D Blanquez Martinez, R Morillo Verdugo

Publikováno v: European Journal of Hospital Pharmacy. 21:A12.1-A12

Background Antiretroviral treatment (ART) has significantly increased the life expectancy of human immunodeficiency virus (HIV)-infected individuals. However, toxicities, comorbidities and treatment failures, among others, may result in frequent ART

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::17f739107e36247240dd02abace8d871
https://doi.org/10.1136/ejhpharm-2013-000436.29